News

Howmet Aerospace Reports Impressive Earnings, Upgrades Guidance

Howmet Aerospace Reports Impressive Earnings, Upgrades Guidance

Strong Quarterly Performance by Howmet Aerospace Inc.

Howmet Aerospace Inc. (NYSE:HWM) experienced a notable surge in its shares on a recent Thursday following the announcement of robust third-quarter financial results that exceeded Wall Street forecasts. The company's performance prompted an upward revision of its full-year outlook across all metrics, showcasing its impressive operational capabilities.

Record Earnings and Revenue

The aerospace components manufacturer reported adjusted earnings per share of 95 cents, surpassing the expected 91 cents. Additionally, the company recorded revenues of $2.089 billion, comfortably above the projected $2.042 billion. This success has been fueled by strong demand within the aerospace sector, driving significant double-digit growth across various segments.

Segment Performance Highlights

Overall revenue increased by 14% when compared to the previous year. This growth was largely attributed to a 15% rise in the commercial aerospace division, a 24% increase in defense aerospace, and an 18% gain in industrial and other markets, which somewhat mitigated the 3% decline noted in the commercial transportation segment.

Robust Income and Cash Generation

The company’s operating income and adjusted operating income both reached $542 million, marking a 29% increase year-over-year. This resulted in an impressive operating margin of 25.9%, reflecting a 300-basis-point improvement. Adjusted EBITDA, excluding special items, increased by 26% year over year to $614 million, while margins improved by 290 basis points to 29.4%. Furthermore, Howmet generated $531 million in cash from operations and achieved a free cash flow of $423 million, showcasing its record cash generation capabilities during the quarter.

Segment-Wise Revenue Breakdown

Diving deeper into performance by segment, the Engine Products revenue soared by 17% to $1.1 billion, with its segment adjusted EBITDA reaching $368 million, reflecting a 20% increase and margins climbing to 33.3%. Fastening Systems revenue also saw a substantial rise, up 14% to $448 million, complemented by adjusted EBITDA growth of 35% to $138 million, expanding margins to 30.8%. Engineered Structures also exhibited growth, with revenues increasing to $289 million, while adjusted EBITDA soared by 53% to $58 million.

Stock Repurchase and Dividend Increase

In the same quarter, the company repurchased $200 million worth of common stock at an average price of $182.20 per share, with an additional $100 million repurchased in October at $191.86 per share. Year-to-date, repurchases have totaled $600 million. Impressively, the board approved a 20% increase to the dividend, which now stands at $0.12 per share.

Looking Ahead: Guidance and Projections

For the fourth quarter of 2025, Howmet anticipates adjusted EPS to fall between $0.94 and $0.96, slightly above the estimate of $0.94. Revenue projections range from $2.090 billion to $2.110 billion compared to estimates of $2.124 billion. The company raised its full-year 2025 guidance across the board, now forecasting adjusted EPS between $3.66 and $3.68, and revenue between $8.175 billion and $8.195 billion, a significant increase from earlier estimates.

Future Market Expectations

Looking toward 2026, Howmet anticipates revenues to approach approximately $9 billion, reflecting a year-over-year growth rate of about 10%. This expected growth is supported by sustained demand within commercial and defense aerospace markets, alongside the expanding industrial sector.

Current Market Status

As of the latest trading check, HWM shares are up by approximately 1.58%, trading at $206.70.

Frequently Asked Questions

What were the main highlights of Howmet Aerospace's quarterly results?

The company reported adjusted earnings per share of 95 cents and revenues of $2.089 billion, both surpassing estimates.

How much did Howmet's revenue increase year-over-year?

Howmet's revenue increased by 14% year-over-year, largely driven by strong demand in aerospace.

What is the outlook for Howmet for the fourth quarter?

Howmet expects adjusted EPS between $0.94 and $0.96 and revenue between $2.090 billion and $2.110 billion.

What significant financial actions has Howmet taken recently?

The company repurchased $200 million in common stock and declared a 20% dividend increase.

What is Howmet's revenue projection for 2026?

Howmet anticipates approximately $9 billion in revenue for 2026, indicating about 10% year-over-year growth.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 83

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 253

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 106

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 231

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 86

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 190

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 127

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 443

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 321

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading

Top 5 Most Recently Viewed Articles

The Exciting Return of Riverdance 30 to U.S. Stages Soon

Updated Category News Views 239

Riverdance 30's Upcoming U.S. Tour Announcement Abhann Productions is set to thrill audiences once again with its renowned spectacle, RIVERDANCE 30 – THE NEW GENERATION. This international dance phenomenon, which has captivated over 30 million people globally, will grace U.S. stages beginning in 2026. Starting in Sarasota, Florida, the tour is scheduled to reach...

Continue Reading
Bluerock Acquisition Corp. Enables Separate Trading for Units

Updated Category News Views 104

Bluerock Acquisition Corp. Separates Trading for Shareholders Bluerock Acquisition Corp. has made an exciting announcement for its investors. The company, known for its strategic approach to investment, has revealed that beginning on or about February 2, 2026, shareholders will have the opportunity to trade their Class A ordinary shares and warrants separately. This...

Continue Reading
Huntington Bancshares Achieves Remarkable Growth in Q3 2025

Updated Category News Views 242

Strong Financial Performance in Q3 2025 Q3 Results Highlighted by Significant Growth in Key Strategic Fee Revenues and Net Interest Income, Driven by Strong Loan Growth and Expanded Net Interest Margin 2025 Third-Quarter Highlights: Earnings per common share (EPS) for the quarter was $0.41, reflecting a positive increase of $0.07 from the previous quarter and $0.08...

Continue Reading
Eaton Corp's Options Trading Insights and Market Reactions

Updated Category News Views 120

Understanding Recent Trends in Eaton Corp Options Trading Recent analysis indicates a notable shift in market sentiment surrounding Eaton Corp (ETN). A closer look at the options history reveals a mix of bullish and bearish activities among traders, creating a compelling narrative worth exploring. Market Sentiment Analysis Upon examining the current options trading...

Continue Reading
Drone Technology Growth Revolutionizing Military Operations

Updated Category News Views 198

Drone Technology Growth Revolutionizing Military Operations The military drone market is witnessing an unprecedented surge in demand as armed forces around the world increasingly rely on unmanned aerial vehicles (UAVs) for a variety of essential applications. These include intelligence gathering, surveillance, reconnaissance, combat missions, and border security. Drones...

Continue Reading